SEC Company Response from CNBX Pharmaceuticals (CNBX) — Oct 14, 2015
CNBX Pharmaceuticals Inc.
Date: Oct. 14, 2015 · CIK: 0001343009 · Accession: 0001019687-15-003713
AI Filing Summary & Sentiment
File numbers found in text: 000-52403
Letter
Re: Cannabics Pharmaceuticals Inc. Form 10-K for the Fiscal Year Ended August 31, 2014 Filed December 15, 2014 File No. 000-52403
Dear Ms. Marlowe,
The Issuer has been preparing its responses to your above-referenced Comments. We are aware of the time delay and now finalizing our last section, which was given out for 3rd party opinion.
We would expect to have these responses presented to you no later than Tuesday, October 20th. Should you have any questions or comments, please do contact me at any time. Thank you for your understanding in this matter.
Sincerely yours,
/s/ David E. Price
Show Raw Text
CORRESP
1
filename1.htm
#3 BETHESDA
METRO CENTRE
SUITE 700
BETHESDA, MD
20814
---------
Tel (877) 424-2429
Cannabics.com
14th October, 2015
US Securities & Exchange Commission
Corporate Finance Division
Washington, DC 20549
Attn: Ms. Julie Marlowe
Re: Cannabics Pharmaceuticals Inc.
Form 10-K for the Fiscal Year Ended August
31, 2014
Filed December 15, 2014
File No. 000-52403
Dear Ms. Marlowe,
The Issuer has been preparing its responses
to your above-referenced Comments. We are aware of the time delay and now finalizing our last section, which was given out for
3rd party opinion.
We would expect to have these responses presented
to you no later than Tuesday, October 20th. Should you have any questions or comments, please do contact me at any time.
Thank you for your understanding in this matter.
Sincerely yours,
/s/ David E. Price
David E. Price, Esq.